Table 2.

Summary for decision-making in different pathologies during phase 2

Pathology	What to operate	What to defer
NSCLC	• Tumor-associated infection—compromising, but not septic (e.g., debulking for post-obstructive pneumonia) • Tumor associated with hemorrhage, not amenable to nonsurgical treatment. • Threatened airway	• As phase 1 in addition to any non-complicated NSCLC by infection or hemorrhage or airway obstruction • Alternatives as phase 1 in addition to referral to phase 1 hospitals
Esophageal cancer	Septic or non-septic perforation only	Non-complicated by perforation cases
Postoperative complications (hemothorax, empyema, infected mesh, dehiscence of airway, anastomotic leak with sepsis)	Hemodynamic stable or unstable patients	Minor wound infections
Others	• All emergency cases as massive hemothorax, major airway injury, airway obstruction by inhaled foreign body or advanced tracheal stenosis, and diaphragmatic hernia with strangulation • Loculated empyema with sepsis that cannot otherwise be treated • Tension emphysematous bullae with respiratory distress • Recurrent pneumothorax with massive air leak	• Pectus surgery • Hyperhidrosis • Bronchiectasis • Tracheal resection in tracheostomized patients • Non-malignant pleural effusion • Elective bullectomy • Retained bullets with no fear of migration or embolization • Empyema that can be drained by chest tube • Pneumothorax for pleurodesis

NSCLC non-small cell lung cancer